ğŸŒ  DAILY RECAP ğŸŒ™

ğŸŒ± ğŸŒ± ğŸŒ± ğŸŒ¿ SLIGHT GAINS: +0.04% ğŸŒ± ğŸŒ± ğŸŒ±

TOP 5 TODAY PERFORMANCE OF PORTFOLIO ğŸ“ˆ
â›ï¸ $GLEN +1.08%
ğŸŒ $IEMG +0.67%
ğŸ§¬ $AZN.L +0.57%
ğŸš¢ $1919.HK +0.36%
ğŸ¦ $IEUR +0.30%

TOP 3 MONTHLY PERFORMANCE OF PORTFOLIO ğŸ“ˆ
ğŸ–¥ï¸ $SNPS +21.12%
ğŸ” $GOOG +12.62%
ğŸ¦ $2318.HK +10.76%

TOP 3 HOLDING YEARLY PERFORMANCE OF PORTFOLIO ğŸ“ˆ
ğŸ›¡ï¸ $PLTR +150.98%
â˜ï¸ $NET +79.84%
âš¡ $CCJ +78.34%

ğŸŒ MARKET NEWS RECAP

**ğŸŒ MARKET OVERVIEW**
Global equities are muted in holiday-thinned trading as the year-end "Santa Claus rally" takes a pause. US stock futures are slightly lower, with $NDAQ 100 futures slipping 0.2% after a strong run last week, while $S&P 500 futures remain little changed. European markets are pointing cautiously higher as $Euro Stoxx 50 futures advanced 0.3% in early trading. In Asia, the $Shanghai Composite was virtually unchanged, but the broader MSCI Asia Pacific Index rose 0.3%, boosted by tech and industrials.

**ğŸ’¼ PORTFOLIO FOCUS**
The AI/Semiconductor complex remains a key focus, with $AVGO reporting a backlog for its AI switches exceeding $10 billion, driven by record demand for its latest Tomahawk 6 chip. $NVDA is also in the spotlight following a new strategic, non-exclusive license agreement with AI chipmaker Groq, a move valued up to $20 billion to integrate Groqâ€™s inference technology and enhance its position in the AI ecosystem. For the healthcare holdings, the trend continues to favor the pharmaceutical sector's exposure to the emerging GLP-1 therapies and domestic markets over US pricing pressures, which impacts $LLY, $NOVO-B, $ABT, $ABBV, $AZN.L, and $HUM. European banking exposure via $SX7PEX.DE is supported by analysts maintaining a positive outlook on the sector's valuation and capital positions. The broader AI-driven boom in digital infrastructure continues to provide tailwinds for enterprise tech names like $MSFT, $GOOG, $AMZN, $PLTR, and $NET.

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”
ğŸ’¡ WHY COPY THIS PORTFOLIO?

ğŸ“ˆ TRACK RECORD:
+170% since strategy change (2020)
~34% average annual return
Double your money in ~2.1 years

âœ… STRATEGY HIGHLIGHTS:
â€¢ Smart diversification across 3 continents
â€¢ Focus on megatrends: AI, Healthcare, Energy
â€¢ Mix of ETFs + high-potential individual stocks
â€¢ Active and transparent management

ğŸ“Š PERFORMANCE DELTA vs. BENCHMARKS (Since 2020):
âœ“ VS $SPX500 : +57% (outperformance)
âœ“ VS $NSDQ100 : -19% (underperformance)
âœ“ VS $SWDA.L : +68% (outperformance)
âœ“ VS $EUSTX50 : +118% (outperformance)
âœ“ VS $CHINA50 : +171% (outperformance)

ğŸ¯ Long-term strategy based on solid fundamentals
ğŸ”„ Periodic rebalancing to optimize risk/reward

@AndreaRavalli
â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”
